Drug product registration and licensing in Europe, Africa, Asia, the Middle East and South America
We are fully experienced, and have specialized skills in providing assistance to international pharma companies who want to register their products in the USA and the European Union. We are also highly adept at managing the registration process for other countries in Europe, Africa, Asia, the Middle East and South America.
We work closely with the highly respected US regulatory consultancy, Strategic Regulatory Consulting.
The CliniExperts team can advise and develop all relevant dossiers that meet specific ACTD, EU CTD, eCTD requirements pertaining to all the scientific disciplines required for successful registration of products in Asian countries, the European Union, and all other countries.
At CliniExperts, we measure our success by the time it takes to secure a product registration through the appropriate regulatory authorities. In this we have an enviable reputation for efficiency and competence.
Initially, we ensure that all data provided by our clients is carefully scrutinised to ensure its adequacy and accuracy. We can guide and advise our clients beforehand so that the submitted data fully meets the requirements for product registration, and eliminates any risk of delay. We also conduct an independent review of the available data to ensure that any potential deficiencies are identified beforehand and corrected during the dossier development process.
For each task, a technical specialist is allocated – either from our in-house team, or from a specialised subcontractor – to ensure efficient project management. A project milestone plan is created and communicated to the client and when the client is satisfied with the logic and timings of the draft plan, the project is initiated for subsequent delivery on time.
A detailed regulatory submission strategy is developed and the dossier documents pertaining to product registration are prepared in sync with the regulations and guidelines of concerned countries. All appropriate information required by the regulatory authority in terms of quality of the product, safety, efficacy, analytical data, validation protocol, etc. is addressed effectively.
Once the data submitted is accepted by the relevant regulatory authority, the product registration takes place in a timely manner. In the event of a query being raised by the authority, a scientific, robust response is presented and the process of obtaining the product registration is expedited.
Navigating Software as a Medical Device regulation involves addressing varying global standards, including risk-based classifications...
The future of Software as a Medical Device will see breakthroughs in Artificial Intelligence-based diagnostics, personalised treatments, and remote monitoring...
Software as a Medical Device refers to software applications designed for medical purposes, such as diagnosis, treatment, or monitoring, without being part of a physical device...
Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.